Company / Accounts Receivable
DNA X, Inc. Accounts Receivable History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$4.3M
FY2024
5-year range
$4.2M / $25.3M
FY2020-FY2024
Trend
-82.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $22M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2024 with a 5-year CAGR of -15.5%.
Declined from $22M to $4M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- -15.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -15.5%, indicating a declining trend.
- In FY2024, accounts receivable decreased 82.9% year-over-year.
- Peak accounts receivable was recorded in FY2023.
- Lowest accounts receivable in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.3M | -82.9% |
| FY2023 | $25.3M | +12.8% |
| FY2022 | $22.4M | +440.3% |
| FY2021 | $4.2M | -9.8% |
| FY2020 | $4.6M | -54.3% |
| FY2019 | $10.1M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026